Constitutive Expression of Peroxisome Proliferator-Activated Receptor α-Regulated Genes in Dwarf Mice
Open Access
- 1 March 2005
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (3) , 681-694
- https://doi.org/10.1124/mol.104.007278
Abstract
Defects in growth hormone secretion or signaling in mice are associated with decreased body weights (dwarfism), increased longevity, increased resistance to stress, and decreases in factors that contribute to cardiovascular disease and cancer. Peroxisome proliferators (PP) alter a subset of these changes in wild-type mice through activation of the nuclear receptor family member PP-activated receptor α (PPARα). We tested the hypothesis that an overlap in the transcriptional programs between untreated dwarf mice and PP-treated wild-type mice underlies these similarities. Using transcript profiling, we observed a statistically significant overlap in the expression of genes differentially regulated in control Snell dwarf mice (Pit-1dw) compared with phenotypically normal heterozygote (+/dw) control mice and those altered by the PP 4-chloro-6-(2,3-xylidino)-2-pyrimidinyl)thioacetic acid (WY-14,643) in +/dw mice. The genes included those involved in β- and ω-oxidation of fatty acids (Acox1, Cyp4a10, Cyp4a14) and those involved in stress responses (the chaperonin, T-complex protein1ϵ) and cardiovascular disease (fibrinogen). The levels of some of these gene products were also altered in other dwarf mouse models, including Ames, Little, and growth hormone receptor-null mice. The constitutive increases in PPARα-regulated genes may be partly caused by increased expression of PPARα mRNA and protein as observed in the livers of control Snell dwarf mice. These results indicate that some of the beneficial effects associated with the dwarf phenotype may be caused by constitutive activation of PPARα and regulated genes.Keywords
This publication has 39 references indexed in Scilit:
- The Transcriptional Response to a Peroxisome Proliferator-activated Receptor α Agonist Includes Increased Expression of Proteome Maintenance GenesJournal of Biological Chemistry, 2004
- Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear ReceptorsJournal of Biological Chemistry, 2004
- Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null miceHepatology, 2002
- p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor αJournal of Biological Chemistry, 2001
- Central Role of Peroxisome Proliferator–Activated Receptors in the Actions of Peroxisome ProliferatorsAnnual Review of Pharmacology and Toxicology, 2000
- Catalase expression in delayed and premature aging mouse models☆Experimental Gerontology, 2000
- Down-Regulation of Cytochrome P450 2C Family Members and Positive Acute-Phase Response Gene Expression by Peroxisome Proliferator ChemicalsMolecular Pharmacology, 1998
- Assessment of the Primary Adrenal Cortical and Pancreatic Hormone Basal Levels in Relation to Plasma Glucose and Age in the Unstressed Ames Dwarf MouseExperimental Biology and Medicine, 1995
- Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643Carcinogenesis: Integrative Cancer Research, 1989
- Carcinogenesis in the Pituitary Dwarf Mouse. The Response to Dimethylbenzanthracene Applied to the SkinBritish Journal of Cancer, 1961